Krystal Biotech Inc (KRYS) — Long-term Investment Intensity
Krystal Biotech Inc (KRYS) has a Long-term Investment Intensity of 13.9% as of March 2026. Long-term investments of $193.49 Million represent 13.9% of total assets of $1.40 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See KRYS total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Krystal Biotech Inc Long-term Investment Intensity (2019–2025)
This chart shows how Krystal Biotech Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2025. As of March 2026, the intensity stands at 13.9%, reflecting long-term investments of $193.49 Million against total assets of $1.40 Billion USD. Also explore Krystal Biotech Inc balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Krystal Biotech Inc (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Krystal Biotech Inc from 2019 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Krystal Biotech Inc (KRYS) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 9.6% | $128.07 Million | $1.33 Billion | ▼ -4.8 pp |
| 2024 | 14.4% | $152.11 Million | $1.06 Billion | ▲ +6.8 pp |
| 2023 | 7.6% | $61.95 Million | $818.36 Million | ▲ +6.7 pp |
| 2022 | 0.8% | $4.62 Million | $558.45 Million | ▼ -9.5 pp |
| 2021 | 10.3% | $64.37 Million | $626.29 Million | ▲ +10.0 pp |
| 2019 | 0.2% | $497.00K | $209.02 Million | — |